Home Industry Reports Custom Research Blogs About Us Contact us

Radiation Oncology Market Size & Share, By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Report ID: FBI 1328


Published Date: Aug-2023


Format : PDF, Excel

Market Outlook:

Radiation Oncology Market size surpassed USD 8.21 Billion in 2022 and is poised to reach USD 23.25 Billion, growing at over 14.14% CAGR between 2023 and 2030. With the rising prevalence of cancer worldwide and the advancements in radiation therapy techniques and technologies, the market valuation is expected to reach unprecedented levels. Radiation oncology, also known as radiation therapy, plays a crucial role in the treatment of various cancers and has become an integral part of cancer care.

Base Year Value (2022)

USD 8.21 Billion

18-23 x.x %
24-33 x.x %

CAGR (2023-2030)


18-23 x.x %
24-33 x.x %

Forecast Year Value (2030)

USD 23.25 Billion

18-23 x.x %
24-33 x.x %
Radiation Oncology Market

Historical Data Period


Radiation Oncology Market

Largest Region

North America

Radiation Oncology Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunities:

1. Increasing Cancer Incidence: The escalating global burden of cancer is a primary growth driver for the radiation oncology market. As the number of cancer cases continues to rise, the demand for radiation therapy as a primary or adjuvant treatment option is expected to increase substantially.

2. Technological Advancements: The constant innovation and development of radiation therapy techniques and technologies offer promising opportunities for market growth. From intensity-modulated radiation therapy (IMRT) to stereotactic body radiation therapy (SBRT), advanced techniques are improving treatment precision and efficacy, resulting in better patient outcomes.

3. Growing Focus on Personalized Medicine: Radiation oncology is witnessing a shift towards personalized medicine, where treatment is tailored to suit individual patient needs. This approach improves treatment outcomes and reduces the risk of potential side effects, thereby driving the demand for radiation oncology products and services.


Industry Restraints & Challenges:

Report Scope

Report CoverageDetails
Segments CoveredType, Technology, Application, Region
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledVarian Medical Systems, Elekta AB, Accuray Incorporated, IBA Radiopharma Solutions, BD, Isoray Medical, Mevion Medical Systems, Nordion, NTP Radioisotopes SOC., Curium Pharma, View ray Technologies,

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

1. High Cost of Radiation Therapy: The cost associated with radiation therapy, including equipment, treatment planning, and maintenance, can be substantial. This high cost can limit the accessibility and affordability of radiation oncology services, particularly in developing and low-income regions, hindering market growth.

2. Shortage of Skilled Professionals: Radiation therapy requires skilled healthcare professionals who can provide accurate treatment planning and ensure the safe delivery of radiation. However, there is a scarcity of adequately trained radiation oncologists and therapists, which can pose a challenge to the market's growth potential.

3. Potential Side Effects: Although radiation therapy is an effective treatment modality, it can cause side effects such as fatigue, skin problems, and in some cases, long-term complications. The fear of potential side effects may deter some patients from opting for radiation oncology, impacting market growth.

In conclusion, the radiation oncology market is anticipated to flourish in the coming years due to the increasing incidence of cancer, technological advancements, and the growing emphasis on personalized medicine. However, challenges such as the high cost of treatment, shortage of skilled professionals, and potential side effects need to be addressed to fully exploit the market's potential.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Radiation Oncology Market
Radiation Oncology Market

Regional Forecast:

The radiation oncology market is expected to witness significant growth in the forecast period across various regions including North America, Asia Pacific, and Europe.

North America:

North America is anticipated to dominate the radiation oncology market during the forecast period. This can be attributed to the increasing incidence of cancer, growing awareness regarding advanced treatment options, and the presence of well-established healthcare infrastructure. Additionally, technological advancements and favorable reimbursement policies are further fueling the market growth in this region.

Asia Pacific:

The Asia Pacific region is projected to exhibit lucrative growth opportunities in the radiation oncology market. Rapidly developing economies such as India and China are witnessing a rising prevalence of cancer, which is expected to drive the demand for radiation oncology treatments. Furthermore, increasing healthcare expenditure, improving healthcare infrastructure, and rising disposable income among the population are boosting the market growth in this region.


Europe is likely to witness considerable growth in the radiation oncology market due to the high adoption rate of advanced radiation therapy technologies. The presence of major market players in this region, coupled with favorable government initiatives and support, is driving the growth of this market. Additionally, the increasing aging population and the rising prevalence of cancer are further contributing to the market expansion in Europe.

Get more details on this report -

Segmentation Analysis:

The radiation oncology market can be segmented based on technology, therapy type, and end-user.

Under technology, one of the sub-segments is Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT).

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (SRS/SBRT) is a highly precise radiation therapy method that delivers a high dose of radiation to a small and well-defined tumor area. It is widely used to treat tumors located in the brain, spine, and other areas of the body. SRS/SBRT offers several advantages such as shorter treatment duration, reduced side effects, and improved patient outcomes. The increasing adoption of SRS/SBRT for the treatment of both primary and metastatic tumors is driving the growth of this sub-segment in the radiation oncology market.

Get more details on this report -

Competitive Landscape:

The radiation oncology market is highly competitive, with several key players driving the growth and development of the industry. Some of the prominent market players include Varian Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications SA, and ViewRay, Inc. These companies are focusing on strategic partnerships, mergers and acquisitions, and product innovations to strengthen their market position. Additionally, they are investing in research and development activities to introduce advanced and technologically advanced radiation therapy systems to cater to the increasing demand for effective cancer treatment options.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Radiation Oncology Market Size & Share, By Type (E...

RD Code : 24